MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-PY-03-0000567
Sunglow Pharmaceuticalss Private Limited - pharma in Puducherry, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.14 Cr
▼ 16% YoY
Net profit · FY 2025
₹73.88 Lakh
Net margin 6.6%
EBITDA · FY 2025
₹1.31 Cr
EBITDA margin 11.8%
Authorised capital
₹6.75 Cr
Registered with MCA
Paid-up capital
₹6.12 Cr
Issued & subscribed
Open charges
₹1 Cr
Satisfied ₹5.19 Cr
Company age
16 yrs
Est. 2010
Employees · EPFO
50
Provident fund records
About Sunglow Pharmaceuticalss Private Limited
Data last updated:
Sunglow Pharmaceuticalss Private Limited is a private limited company based in Puducherry, India, a subsidiary of Sunglow Lifescience Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 January 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Pondicherry, under CIN U24232PY2010PTC002407. Its GSTIN is 34AANCS8501Q1ZP (Puducherry). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹6.75 Cr and a paid-up capital of ₹6.12 Cr. It is led by directors Veerabadran Rajasekaran and Kamaraj.
Its last annual general meeting (AGM) was held on 25 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Plot No.29 – 38 Opposite To Co – Op Milk Dairy (Ponlait) Kurumbapet, Puducherry, India – 605009.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.14 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹73.88 Lakh (net margin 6.6%) and EBITDA of ₹1.31 Cr (EBITDA margin 11.8%). Revenue has declined at a compounded annual rate (CAGR) of 16% over three years.
The company has about 50 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
As per MCA filings, the company has open charges of ₹1 Cr and satisfied charges of ₹5.19 Cr on record.
Sunglow Pharmaceuticalss Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PY-03-0000567). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sunglowpharma.com.
Company details
CIN U24232PY2010PTC002407
Registration Number 002407
Incorporation Date 18 January 2010
ROC Pondicherry
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Sunglow Lifescience Private Limited
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-PY-03-0000567
Key People
Veerabadran Rajasekaran Director Kamaraj Director Recognitions & Rankings of Sunglow Pharmaceuticalss
Contact details
Sunglow Pharmaceuticalss Private Limited's registered office is in Puducherry, Puducherry. Its website is sunglowpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.29 – 38 Opposite To Co – Op Milk Dairy (Ponlait) Kurumbapet, Puducherry, India – 605009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Comprehensive company report
Sunglow Pharmaceuticalss Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sunglow Pharmaceuticalss is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Financials of Sunglow Pharmaceuticalss Private Limited
FY 2024 filings availableSunglow Pharmaceuticalss Private Limited reported revenue of ₹11.14 Cr (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹11.14 Cr ▼ 16%
Net profit · FY 2025
₹73.88 Lakh margin 6.6%
EBITDA · FY 2025
₹1.31 Cr margin 11.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▼ 16%
EBITDA CAGR growth
1 year
▼ 43%
Revenue has declined at a compounded annual rate (CAGR) of 16% over three years, including a 16% fall in the latest year. EBITDA fell 43% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.31 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹73.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 11.8% | ||||
| Net Profit Margin | 6.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Board of directors of Sunglow Pharmaceuticalss Private Limited
Sunglow Pharmaceuticalss has 2 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Veerabadran Rajasekaran Also directs: Sunglow Lifescience Private Limited | Director | 09 Sep 2013 | 13 Years 1 Months | Current |
| Kamaraj Also directs: Apex Innotech LLP, Sunglow Lifescience Private Limited | Director | 28 May 2010 | 16 Years 4 Months | Current |
Peer comparison
Sunglow Pharmaceuticalss Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Empree Medicaments (India) Private Limited | ₹11.19 Cr (FY 2024) | -31.0% | Mumbai, Maharashtra, India | |||
| Navketan Pharma Pvt Ltd | ₹11.17 Cr (FY 2024) | 55.0% | Aurangabad, Maharashtra, India | |||
| Unimax Laboratories Private Limited | ₹11.14 Cr (FY 2025) | 19.0% | Thane, Maharashtra, India | |||
| Sunglow Pharmaceuticalss Private Limitedthis company | ₹11.14 Cr (FY 2025) | ₹73.88 Lakh | 6.6% | -16.0% | 50 | Puducherry, India |
| Cygnus Pharmaceuticals Private Limited | ₹11.13 Cr (FY 2018) | -36.0% | Kolkata, West Bengal, India | |||
| VC Laboratories Private Limited | ₹11.12 Cr (FY 2018) | -21.0% | Hyderabad, Telangana, India | |||
| Sovereign Remedies Pvt. Ltd. | ₹11.11 Cr (FY 2016) | 26.0% | Indore, (M.P..), Madhya Pradesh, India |
To see the full peer comparison of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Auditor
Sunglow Pharmaceuticalss Private Limited is audited by Betala & Associates for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Betala & Associates | FY 2024 | 011580S |
Shareholding
The shareholding of Sunglow Pharmaceuticalss Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1 Cr
Satisfied charges
₹5.19 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 14 Feb 2017 | 100096074 | Axis Bank Limited | ₹1 Cr | Open | |
| 30 Jul 2020 | 100360502 | Axis Bank Limited | ₹60 Lakh | Satisfied | |
| 28 Nov 2013 | 10464827 | Hdfc Bank Limited | ₹3.34 Cr | Satisfied | |
| 21 Mar 2011 | 10281812 | Uco Bank | ₹1.25 Cr | Satisfied |
To see the full charge records of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Sunglow Pharmaceuticalss Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Sunglow Pharmaceuticalss Private Limited has 3 MSME Form 1 returns on record between 2017 and 2019, listing 115 overdue payments to 108 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 108)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Spoton Logistics Pvt Ltd | |||
| an individual supplier | |||
| All Packs | |||
| Colorcon Asia Private Limited | |||
| G4s Secure Solutions (India) Private Limited |
To see the full MSME payment records of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Sunglow Pharmaceuticalss has 1 subsidiary company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
1
Subsidiary companies
Key subsidiaries
| Company Name | CIN | Shares held |
|---|---|---|
| Relimed Pharmaceuticals Private Limited | U74990TN2011PTC078845 |
To see the full group structure of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Employees & EPFO
Sunglow Pharmaceuticalss Private Limited has a workforce of 50 employees on its EPFO records as of Mar 22, 2024, across 1 active EPFO establishment.
Employee count
50
Active EPFO establishments
1
Employee growth
2.04%
GST
Sunglow Pharmaceuticalss has 2 GST registrations: 1 active and 1 cancelled or inactive.
Total GSTINs
2
Active
1
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 34AANCS8501Q1ZP | Puducherry | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sunglow Pharmaceuticalss Private Limited, buy the company report.
Recent activity
Sunglow Pharmaceuticalss Private Limited has 15 board changes on record since 2010: 2 appointments and 13 cessations. The latest: Tirukkurungudi Seshadri Srinivasan ceased to be Company Secretary on 31 Jan 2020.
Charges
A charge with Axis Bank Limited of Rs. 1.00 Cr registered on 14 Feb 2017 with Charge ID 100096074 was modified on 03 Jul 2025.
AGM
Sunglow Pharmaceuticalss Private Limited last Annual general meeting of members was held on 25 Sep 2024 as per latest MCA records.
Filing
Sunglow Pharmaceuticalss Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pondicherry.
Charges
A charge registered on 30 Jul 2020 via Charge ID 100360502 with Axis Bank Limited was fully satisfied on 17 Dec 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.60 Cr with Charge ID 100360502 was registered on 30 Jul 2020.
Ceased
Tirukkurungudi Seshadri Srinivasan ceased to be Company Secretary.
Ceased
Sundararajalu ceased to be Additional Director.
Ceased
Kandoth Kunnumpreth Vinupal ceased to be Director.
Ceased
Paramasivan Sivarajakumar ceased to be Director.
Charges
A charge registered on 28 Nov 2013 via Charge ID 10464827 with Hdfc Bank Limited was fully satisfied on 15 Apr 2017.
Ceased
Sowrinathan ceased to be Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 1.00 Cr with Charge ID 100096074 was registered on 14 Feb 2017.
16 earlier events are in the company report.
Frequently asked questions
Sunglow Pharmaceuticalss is an active private limited company based in Puducherry, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 January 2010 (16+ years old) and is registered under CIN U24232PY2010PTC002407.
Sunglow Pharmaceuticalss has 2 current directors:
- Veerabadran Rajasekaran - Director
- Kamaraj - Director
The latest financial statements of Sunglow Pharmaceuticalss on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 25 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Sunglow Pharmaceuticalss is 34AANCS8501Q1ZP, registered in Puducherry. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sunglow Pharmaceuticalss is U24232PY2010PTC002407. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sunglow Pharmaceuticalss was incorporated on 18 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Pondicherry.
The peers of Sunglow Pharmaceuticalss by revenue are Empree Medicaments (India) Private Limited, Navketan Pharma Pvt Ltd, Unimax Laboratories Private Limited, Cygnus Pharmaceuticals Private Limited, VC Laboratories Private Limited and 1 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tirukkurungudi Seshadri Srinivasan ceased to be Company Secretary on 31 Jan 2020. Sundararajalu ceased to be Additional Director on 15 Jun 2018. Kandoth Kunnumpreth Vinupal ceased to be Director on 31 Mar 2018. Sunglow Pharmaceuticalss has 15 board changes on record in total.
Yes, Sunglow Pharmaceuticalss is registered as a small enterprise under Udyam registration (number: UDYAM-PY-03-0000567).
Sunglow Pharmaceuticalss has 3 MSME Form 1 returns on record between 2017 and 2019, listing 115 overdue payments to 108 micro and small suppliers. The latest return was filed on 31 May 2019.
Sunglow Pharmaceuticalss can be reached through the website sunglowpharma.com. Its registered office is in Puducherry, India.
The registered office of Sunglow Pharmaceuticalss is at Plot No.29 – 38 Opposite To Co – Op Milk Dairy Ponlait Kurumbapet, Puducherry, India – 605009.